DSM proposes appointment of new Chief Financial Officer
10 3월 2014 - 3:00PM
The
Supervisory Board of Royal DSM, the
Life Sciences and Materials Sciences company, is pleased to
announce that it will propose to appoint Geraldine Matchett
(42) as Member of the Managing Board
of Directors as of 1 August 2014. As from 1 December 2014, she will
then become Chief Financial Officer of Royal DSM, succeeding
Rolf-Dieter Schwalb, who currently holds that position. The
proposal will be tabled at the Annual General Meeting of
shareholders on Wednesday, 7 May 2014.
Geraldine Matchett is currently the Global Chief
Financial Officer and member of the Operations Council of the SGS
Group, a publicly quoted company on the SIX Swiss stock exchange
and the world leading company in inspection, verification, testing
and certification with 80,000 employees and annual revenues of
approximately CHF 6 billion.
Geraldine has three nationalities (Swiss, British
and French) and has previously worked in London for KPMG and in
Switzerland for Deloitte as financial auditor and audit manager,
handling clients in the food, pharma and chemical sectors. She has
extensive experience with interaction with all relevant
stakeholders, has been actively involved in corporate development
activities and has managed many areas of the finance function
across the world. She was recently voted CFO of the year in
Switzerland for large companies.
Rolf-Dieter Schwalb has been the DSM CFO for 8
years, during which the company completed its transformation into a
Life Sciences and Materials Sciences company. He will step down as
CFO as of December 1, but he will remain available for assistance
till 2014 financial closing. The members of the DSM Managing Board
and Supervisory Board wish to thank Mr. Schwalb for his
contribution to DSM, his leadership in the finance area and his
drive for integrated reporting and increased transparency. He has
also been very instrumental in the shifts in DSM's portfolio, where
his background brought fresh perspectives to the table.
DSM - Bright Science.
Brighter Living.(TM)
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in
Life Sciences and Materials Sciences DSM is driving economic
prosperity, environmental progress and social advances to create
sustainable value for all stakeholders simultaneously. DSM delivers
innovative solutions that nourish, protect and improve performance
in global markets such as food and dietary supplements, personal
care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based
materials. DSM's 24,500 employees deliver annual net sales of
around €10 billion. The company is listed on NYSE Euronext.
More information can be found at www.dsm.com.
For more
information:
DSM Corporate Communications Herman Betten
tel. +31 (0) 45 5782017
e-mail media.relations@dsm.com |
DSM Investor Relations Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.com |
Geraldine Matchett
Press release-pdf
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Globenewswire
HUG#1767379
Royal DSM NV (QX) (USOTC:RDSMY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Royal DSM NV (QX) (USOTC:RDSMY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024